関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
アブシシ酸受容体によるホルモンシグナル伝達のためのゲート・ラッチ・ロック・メカニズム
Karsten Melcher1, Ley-Moy Ng, X Edward Zhou
1Laboratory of Structural Sciences, Van Andel Research Institute, 333 Bostwick Avenue, N.E., Grand Rapids, Michigan 49503, USA.
Nature
|November 10, 2009
まとめ
アブシシ酸 (ABA) 信号伝達は,ホルモンを結合するPYR/PYL/RCAR受容体を含む. この結合は,ゲート・ラッチ・ロック・メカニズムを誘発し,PP2Cフォスファタゼを抑制し,植物反応を調節する.
科学分野:
- 植物生物学 植物生物学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- アブシシ酸 (ABA) は,成長,発達,ストレス反応を調節する重要な植物ホルモンです.
- PYR/PYL/RCARタンパク質はABAの作用を媒介するが,ホルモン結合とダウンストリーム阻害の正確なメカニズムは不明である.
研究 の 目的:
- PYR/PYL/RCAR受容体によるABA知覚と信号伝達の構造的メカニズムを解明する.
- ABAが受容体に結合すると,2C型タンパク質フォスファタゼ (PP2Cs) が抑制される仕組みを理解する.
主な方法:
- X線結晶学を用いて,apoとABA結合のPYR/PYL/RCAR受容体の構造を決定した.
- 相互作用を視覚化するために,PYL2-ABA-PP2Cの三元複合構造が決定されました.
主要な成果:
- アポ受容体は,オープンなリガンド結合ポケットを持っています.
- ABA結合は,保存されたβループの構造変化を誘導し,ゲートとラッチメカニズムを閉じます.
- このABA誘発の閉塞は,PP2C結合のための阻害的なインターフェースを作り,さらに保存されたトリプトファンによって安定させます.
結論:
- 保存されたゲート・ラッチ・ロック・メカニズムは,ABAの知覚とシグナリングを制御する.
- このメカニズムは,ABAがPYR/PYL/RCAR受容体と結合すると,PP2Cが抑制される仕組みを説明しています.
- この発見は,ABA媒介の植物反応を理解するための構造的基礎を提供します.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K